The pleiotropic transcription factor YY1, another key figure in this study, was found to exhibit markedly differential expression in HCC tissues responding to and resistant to anti‐PD‐1 therapy, as identified by proteomic profiling. Here, YY1 is linked to hepatocellular carcinoma.